Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation

Immune checkpoint inhibitors (ICIs) have been applied to clinical practice and achieved significant therapeutic benefit in a variety of human malignancies. These drugs not only enhance the body’s antitumor immune response but also produce side effects called immune-related adverse events (irAEs). Al...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Shicong Zhu, Yang Fu, Bo Zhu, Bicheng Zhang, Jun Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-09-01
Subjects:	immune-related adverse events programmed cell death 1 programmed cell death ligand 1 immune checkpoint inhibitor pneumonitis
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.01785/full